Gitelman Syndrome

Understanding gitelman syndrome requires examining multiple perspectives and considerations. IL-6 Receptor Inhibitors Show Early Promise for CPPD - Medscape. The group went on to test tocilizumab in 10 additional patients with CPPD (median age, 62.5 years), including six with idiopathic CPPD, three with Gitelman syndrome, and one with ANKH mutation. Vitamin B12 Cuts Risk for Chemotherapy Hand-Foot Syndrome.

Building on this, oral vitamin B12 halves the rate of moderate-to-severe capecitabine-induced hand-foot syndrome in patients with breast cancer. SJS/TEN Survivors Face Long-Term Burden - Medscape. A US study finds that survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis face lasting physical, psychological, and social effects and often lack coordinated follow-up care. Medscape | Med Clin (Barc) - Content Listing. [ MEDLINE Abstract ] Gitelman syndrome and type 1 diabetes mellitus: An uncommon association. August 21, 2023 [ MEDLINE Abstract ] Myelodysplastic neoplasms.

Altered Lung Aeration Tied to Surfactant in Preemies - Medscape. Building on this, the right lungs are more aerated than the left lungs after surfactant therapy in infants born preterm with respiratory distress syndrome, a study shows. Benralizumab Shows Benefits for Hypereosinophilic Syndrome. Another key aspect involves, benralizumab is an anti-IL-5Ra antibody that causes a nearly complete depletion of eosinophils and has demonstrated effectiveness in patients with severe asthma and eosinophilic granulomatosis ...

Novel PRP Approach Improves GSM in Cancer Survivors - Medscape. A single treatment of platelet-rich plasma injected into the vagina and posterior fourchette is safe and feasible for treating genitourinary syndrome of menopause (GSM) in breast cancer survivors ... Which Works Better for IBS: Rifaximin or Low-FODMAP Diet?. It's important to note that, rifaximin is as effective as the low-FODMAP diet in managing irritable bowel syndrome and offers quicker symptom relief and higher adherence to treatment, a recent trial suggests.

Oral Niacinamide Linked to Lower CV Event Risk - Medscape. Equally important, patients receiving oral niacinamide for nonmelanoma skin cancer chemoprophylaxis show fewer cardiac events, a retrospective cohort study finds. High Mortality Linked to Enfortumab Vedotin Skin Toxicity. A postmarketing report shows that enfortumab vedotin related skin toxicity is associated with high risk for mortality, particularly SJS/TEN.